Impact of Prolonged Continuous Ketamine Infusions in Critically Ill Children: A Prospective Cohort Study
Pediatric Drugs · 2024
DOI: 10.1007/s40272-024-00635-9 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pediatric Drugs, 2024. Verfasst von Paulo Sérgio Lucas da Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Pediatric Intensive Care Unit, Hospital Estadual de Diadema, Rua José Bonifácio 1641, São Paulo, 09980-150, Brazil. psls.na…. Hauptthemen laut MEDLINE: Ketamine, Critical Illness, Intensive Care Units, Pediatric. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Pediatric Intensive Care Unit, Hospital Estadual de Diadema, Rua José Bonifácio 1641, São Paulo, 09980-150, Brazil. psls.nat@terra.com.br.
- Department of Pediatrics, Pediatric Intensive Care Unit, Hospital Estadual de Diadema, Rua José Bonifácio 1641, São Paulo, 09980-150, Brazil.
- Health Technologies Assessment Center, Federal University of São Paulo, São Paulo, Brazil.
Zitieren
APA
da Silva, P. S. L., Kubo, E. Y., da Motta Ramos Siqueira, R., & Fonseca, M. C. M. (2024). Impact of Prolonged Continuous Ketamine Infusions in Critically Ill Children: A Prospective Cohort Study. Pediatric Drugs. https://doi.org/10.1007/s40272-024-00635-9
Vancouver
da Silva PSL, Kubo EY, da Motta Ramos Siqueira R, Fonseca MCM. Impact of Prolonged Continuous Ketamine Infusions in Critically Ill Children: A Prospective Cohort Study. Pediatric Drugs. 2024. doi:10.1007/s40272-024-00635-9
BibTeX
@article{daSilva2024,
author = {da Silva, Paulo Sérgio Lucas and Kubo, Emerson Yukio and da Motta Ramos Siqueira, Rafael and Fonseca, Marcelo Cunio Machado},
title = {Impact of Prolonged Continuous Ketamine Infusions in Critically Ill Children: A Prospective Cohort Study},
journal = {Pediatric Drugs},
year = {2024},
doi = {10.1007/s40272-024-00635-9}
}
EUVIMED